Berberine Dosage: How Much to Take, and Why 500 mg ×3
Quick answer
500 mg, 2–3× a day (1,000–1,500 mg/day), taken with or just before meals — the dose in nearly every positive trial. Split it because berberine is poorly absorbed and can upset your stomach at first; ramp up over 1–2 weeks. It has genuine, modest effects on blood sugar and cholesterol — but it is not "nature's Ozempic," and it interacts with real medications.
Informational summary of published research — not medical advice. Berberine has real drug interactions; if you take any prescription medication, check with your doctor or pharmacist first. Do not use in pregnancy or breastfeeding.
As an Amazon Associate we earn from qualifying purchases. Picks are ranked by dose, testing, and cost, never commissions.
Dose by goal (what the trials used)
| Goal | Studied dose | Evidence |
|---|---|---|
| Blood sugar / type 2 diabetes | 500 mg ×2–3/day | Moderate — lowers HbA1c & fasting glucose (meta-analyses); mostly small China trials |
| Cholesterol / lipids | 500 mg ×2–3/day | Moderate — lowers LDL & triglycerides, raises HDL |
| PCOS (insulin resistance) | 500 mg ×3/day | Modest — similar to metformin on HOMA-IR in small trials; live-birth not shown |
| Weight | 500 mg ×3/day | Weak — ~1–2 kg, inconsistent; not a weight-loss drug |
Sources: diabetes — Guo 2021 (PMID 34956436), Xie 2022 (PMID 36467075); vs metformin — Yin 2008 (PMID 18442638, small pilot); lipids — Ju 2018 (PMID 30466986); PCOS — Li 2018 (PMID 30538756); weight — Asbaghi 2020 (PMID 32690176). Much of the base is small, heterogeneous trials — real but modest, low-to-moderate confidence.
Find your berberine dose
Pick your reason. You'll get the trial dose and an honest read on the evidence.
The "nature's Ozempic" myth. Berberine went viral as a natural semaglutide. It isn't. Semaglutide produced about 15% body-weight loss in its trial (STEP 1); berberine produces roughly 1–2% (~1–2 kg), and some analyses find no significant weight effect at all (Amini 2020). Different mechanism, roughly ten-fold different magnitude. Berberine's real value is modest help with blood sugar and lipids — not weight loss.
Why it's split, and why absorption matters
Berberine is notoriously poorly absorbed — studies estimate that around 99% of an oral dose never reaches your bloodstream, largely because a gut transporter (P-glycoprotein) pumps it straight back out (Kwon 2020). That's why the dose is split across meals rather than taken as one big pill. Some products use dihydroberberine, a more-absorbable form that reaches higher blood levels at a lower dose in early human data (Moon 2021, small pilot) — promising for absorption, but not yet shown to improve real outcomes.
Original research · Verified Supplement Data
What the label tells you to take
We read the Supplement Facts panel of 431 on-market berberine labels in the NIH Dietary Supplement Label Database, and multiplied each serving by the maximum daily servings the label directs. That product — not the number on the front of the bottle — is the dose the label instructs.
- On the market
- 431
- Panels read
- 431
- Declaring a dose
- 305
- Stating a schedule
- 427
- Dose & schedule both
- 295
| Measure | 10th pct | Median | 90th pct |
|---|---|---|---|
| Per serving | 125 mg | 500 mg | 1,200 mg |
| As the label directs, per day | — | 1,000 mg | 1,500 mg |
| Servings per day | Labels | Share |
|---|---|---|
| 1 | 212 | 50% |
| 2 | 122 | 29% |
| 3 | 89 | 21% |
| 4 | 3 | 1% |
| 6 | 1 | <1% |
Which form the market actually sells
- Berberis aristata 69%
- Berberine Hydrochloride 13%
- Indian Barberry 8%
- Indian Barberry Root Extract 6%
- Berberis aristata extract 6%
Share of 127 chemical-form declarations across 431 labels — a single panel can name more than one.
What the top-ranking pages say
UCLA Health, GoodRx and Ohio State all describe the same shape: berberine capsules are typically 500 mg, labels usually say to take one two or three times a day, and the studied range is roughly 1,000-1,500 mg daily. That is accurate as far as it goes. None of them checks what the shelf actually does with it.
What our measurement adds
We read every one of the 431 berberine labels on the US market — the whole market, not a sample. A 500 mg capsule is indeed the median. But 77% of single servings fall below the studied DAILY dose, and only half the market's labels direct the two or three servings that close the gap. "Capsules are 500 mg and you take a few" is right in outline and hides the part that decides whether you got a dose at all.
What this means: One berberine capsule is not a dose, and the bottle is only sometimes the thing that tells you. Trials ran 1000-1500 mg a day, split across meals, because roughly 99% of an oral dose is never absorbed and a single large one mostly irritates the gut. Taken exactly as their own labels direct, 50% of products land inside the studied range and 45% land under it. The practical version: multiply the panel figure by the servings the label directs, before you buy. If the product lands under 1,000 mg a day, it cannot reproduce the trials whatever the front of the bottle claims.
What to look for on the shelf
Multiply the panel figure by the servings the label directs before you buy, and want the answer at 1,000–1,500 mg. Products built to reach it exist and are the minority — the picks below show which products reach it and at how many capsules a day — the number to want is 1,000 mg or more of actual berberine per day, however the label splits it.
What this cannot tell you: This measures what labels declare and direct, not what a capsule contains and not what you absorb — berberine's poor absorption is the reason the dose is split at all, and it varies between people and formulations. Nor does reaching the trial dose mean getting the trial result: the underlying studies are mostly small, short and conducted in China, and the effects on blood sugar and lipids they found are real but modest. Hitting 1,500 mg a day is a precondition for that evidence applying to you, not a promise that it will.
Source: NIH Dietary Supplement Label Database (DSLD) v9, read 2026-08-29. Of 3 properties tested against the sample, 1 held independently in both halves of the read order — and only those are claimed here.
Products to hit the dose — priced per day, not per capsule
Berberine is the supplement where cost per capsule misleads most, because the trial dose takes anywhere from one serving to three depending on the product. These are priced at what a day at 1,000 mg actually costs, which reorders the shelf: the cheapest capsule here is the most expensive day.
1,200 mg in a single serving, so one serving is a full trial dose. Cheapest way to actually reach 1,000–1,500 mg — though still worth splitting around meals for tolerability.
1 × 1,200 mg = 1,200 mg/day · 1 × $0.76
1,000 mg in one serving and NSF Certified for Sport — third-party tested for label accuracy and contaminants. The one to pick if verification matters more than price.
1 × 1,000 mg = 1,000 mg/day · 1 × $1.47
400 mg a serving, which is the easiest to titrate up with — but it takes three servings to reach the trial dose, and that makes it the most expensive of the three per day, not the cheapest.
3 × 400 mg = 1,200 mg/day · 3 × $0.73
Compare all picks on the best berberine ranking.
Frequently asked questions
How much berberine should I take per day?
500 mg 2–3× a day (1,000–1,500 mg total) with meals — the dose in nearly every positive trial. Split it (poor absorption + GI tolerance) and ramp up over 1–2 weeks. Not for pregnancy/breastfeeding.
Is berberine really "nature's Ozempic"?
No. Berberine gives ~1–2 kg (1–2%) weight change (some studies none); semaglutide gave ~15% — roughly 10× more, via a different mechanism. It's not a GLP-1 drug or a substitute. Its real value is modest blood-sugar and cholesterol help.
When should I take berberine?
With food or just before meals (it blunts the post-meal glucose rise), split into 2–3 doses to keep exposure steady and reduce early GI effects.
Does berberine interact with medications?
Yes — importantly. It inhibits CYP3A4/P-glycoprotein and can raise levels of statins, cyclosporine (+~89% in one study), and other drugs, and adds to diabetes-med glucose lowering. Check with your doctor/pharmacist if you take any prescription.
How long to work, and should I cycle it?
Trials ran 8–24 weeks, so give it ~2 months. No cycling schedule is trial-tested — breaks are convention, not evidence. Given the interactions, use it with medical oversight.
Related
- Berberine: what the evidence shows — does it work, and for what
- Best Berberine Supplement — verified picks ranked
- Berberine Side Effects — GI issues and drug interactions, in full
Sources
- Yin J, et al. "Efficacy of berberine in patients with type 2 diabetes mellitus." Metabolism. 2008. PMID: 18442638
- Xie W, et al. "Glucose-lowering effect of berberine on type 2 diabetes: meta-analysis." Front Pharmacol. 2022. PMID: 36467075
- Ju J, et al. "Efficacy and safety of berberine for dyslipidaemias: meta-analysis." Phytomedicine. 2018. PMID: 30466986
- Asbaghi O, et al. "Effect of berberine supplementation on obesity parameters." Clin Nutr ESPEN. 2020. PMID: 32690176
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)." N Engl J Med. 2021. PMID: 33567185
- Kwon M, et al. "Enhanced Intestinal Absorption and Pharmacokinetics of Berberine." Pharmaceutics. 2020. PMID: 32957491
- Wu X, et al. "Effects of berberine on cyclosporine blood concentration." Eur J Clin Pharmacol. 2005. PMID: 16133554
- Guo Y, et al. "Repeated berberine inhibits cytochrome P450." Eur J Clin Pharmacol. 2012. PMID: 21870106
- Chan E. "Displacement of bilirubin from albumin by berberine." Biol Neonate. 1993. PMID: 8513024
- Guo J, et al. “The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Oxidative medicine and cellular longevity. 2021. PMID: 34956436
- Ji L, et al. “Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial.” JAMA network open. 2025. PMID: 40029660
- Mansour A, et al. “The efficacy and safety of berberine in combination with cinnamon supplementation in patients with type 2 diabetes: a randomized clinical trial.” European journal of nutrition. 2025. PMID: 39998703
- Zhao JV, et al. “Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial.” Nutrients. 2021. PMID: 34444711
- Xiong P, et al. “The effect of berberine supplementation on obesity indices: A dose- response meta-analysis and systematic review of randomized controlled trials.” Complementary therapies in clinical practice. 2020. PMID: 32379652
- Qiu Y, et al. “Berberine treatment for weight gain in patients with schizophrenia by regulating leptin rather than adiponectin.” Asian journal of psychiatry. 2022. PMID: 34773803
- Zhao H, et al. “Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.” Reproductive health. 2021. PMID: 34407851
- Mirzaee F, et al. “The effect and safety of Berberine on polycystic ovary syndrome: a systematic review.” Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2021. PMID: 32811221
- Xiang ZD, et al. “Protoberberine alkaloids: A review of the gastroprotective effects, pharmacokinetics, and toxicity.” Phytomedicine : international journal of phytotherapy and phytopharmacology. 2024. PMID: 38367423
- Moon JM, et al. “Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial.” Nutrients. 2021. PMID: 35010998
- Lan J, et al. “Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.” Journal of ethnopharmacology. 2015. PMID: 25498346
- Suadoni MT, et al. “Berberine for the treatment of hypertension: A systematic review.” Complementary therapies in clinical practice. 2021. PMID: 33461163
- Xu L, et al. “A Phase I Trial of Berberine in Chinese with Ulcerative Colitis.” Cancer prevention research (Philadelphia, Pa.). 2020. PMID: 31619442
- Nie Q, et al. “The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.” Journal of translational medicine. 2024. PMID: 38429794
- Shi L, et al. “Berberine and health outcomes: an overview of systematic reviews.” BMC complementary medicine and therapies. 2025. PMID: 40269802
- Harrison SA, et al. “A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes.” Nature communications. 2021. PMID: 34535644
- Panigrahi A, et al. “Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial.” BMC endocrine disorders. 2023. PMID: 37679692
- Zhang Y, et al. “Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.” The Journal of clinical endocrinology and metabolism. 2008. PMID: 18397984
- Blais JE, et al. “Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.” Drugs. 2023. PMID: 36941490
- Zhang Y, et al. “The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial.” Trials. 2016. PMID: 27769284
- Li Y, et al. “Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial.” Trials. 2013. PMID: 23866924
- Koperska A, et al. “Does berberine impact anthropometric, hepatic, and metabolic parameters in patients with metabolic dysfunction-associated fatty liver disease? Randomized, double-blind placebo-controlled trial.” Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 2024. PMID: 39042390
- Koperska A, et al. “The Influence of Berberine on Vascular Function Parameters, Among Them VEGF, in Individuals with MAFLD: A Double-Blind, Randomized, Placebo-Controlled Trial.” Nutrients. 2025. PMID: 41305635